FindTrial
Sign In

Research on the evaluation function of AMH, INHB and INHA in children's sexual development

Research on the evaluation function of AMH, INHB and INHA in children's sexual development

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052250
Enrollment
Unknown
Registered
2021-10-23
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual development related diseases

Interventions

case series:None

Sponsors

Children's Hospital Affiliated to Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: Aged 2-17 years, half male and female.

Exclusion criteria

Exclusion criteria: 1. Clinically diagnosed as sexual developmental disorders such as sexual developmental delay and abnormal sexual differentiation. 2. Clinically diagnosed with endocrine diseases such as congenital hypothyroidism, congenital adrenal hyperplasia, adrenal tumor, and hypothalamic-pituitary tumor. 3. Hormone therapy such as GnRH-a within one year. 4. The remaining amount of hemolysis, lipemia, and serum samples is not enough to complete the test.

Design outcomes

Primary

MeasureTime frame
Anti-Müllerian hormone;Inhibin A;Inhibin B;—

Countries

China

Contacts

Public ContactFu Junfen

Children's Hospital Affiliated to Zhejiang University School of Medicine

fjf68@qq.com+86 571 88873013

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026